TLR4 and osteosarcoma: These data are also consistent with the study of Yahiro et al., who reported in a murine osteosarcoma model that TLR4 activation by systemic administration of lipopolysaccharide (LPS) can suppress the progression of OsA via stimulation and infiltration of CD8+ T-cells [26].